Article thumbnail

Transmission of Mitochondrial DNA Diseases and Ways to Prevent Them

By Joanna Poulton, Marcos R. Chiaratti, Flávio V. Meirelles, Stephen Kennedy, Dagan Wells and Ian J. Holt

Abstract

Recent reports of strong selection of mitochondrial DNA (mtDNA) during transmission in animal models of mtDNA disease, and of nuclear transfer in both animal models and humans, have important scientific implications. These are directly applicable to the genetic management of mtDNA disease. The risk that a mitochondrial disorder will be transmitted is difficult to estimate due to heteroplasmy—the existence of normal and mutant mtDNA in the same individual, tissue, or cell. In addition, the mtDNA bottleneck during oogenesis frequently results in dramatic and unpredictable inter-generational fluctuations in the proportions of mutant and wild-type mtDNA. Pre-implantation genetic diagnosis (PGD) for mtDNA disease enables embryos produced by in vitro fertilization (IVF) to be screened for mtDNA mutations. Embryos determined to be at low risk (i.e., those having low mutant mtDNA load) can be preferentially transferred to the uterus with the aim of initiating unaffected pregnancies. New evidence that some types of deleterious mtDNA mutations are eliminated within a few generations suggests that women undergoing PGD have a reasonable chance of generating embryos with a lower mutant load than their own. While nuclear transfer may become an alternative approach in future, there might be more difficulties, ethical as well as technical. This Review outlines the implications of recent advances for genetic management of these potentially devastating disorders

Topics: Review
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2920841
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2010). 174th ENMC International workshop: applying pre-implantation genetic diagnosis to mtDNA diseases: implications of scientific advances
  2. (2000). 74th ENMC international workshop: mitochondrial diseases
  3. (2003). A Balbiani body and the fusome mediate mitochondrial inheritance during Drosophila oogenesis.
  4. (2008). A functionally dominant mitochondrial DNA mutation.
  5. (2008). A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations.
  6. (1997). A New mtDNA mutation showing accumulation with time and restriction to skeletal muscle.
  7. (2008). A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes.
  8. (1987). Amounts of mitochondrial DNA and abundance of some mitochondrial gene transcripts in early mouse embryos.
  9. (2006). Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis.
  10. (2005). Apoptosis in the ovary: molecular mechanisms.
  11. (1998). Apparent continuity between the messenger transport organizer and late RNA localization pathways during oogenesis in Xenopus.
  12. (1969). Apparent turnover of mitochondrial deoxyribonucleic acid and mitochondrial phospholipids in the tissues of the rat.
  13. (2008). Autophagy is essential for preimplantation development of mouse embryos.
  14. (1995). Clark A
  15. (1998). Decreased physical performance of congenic mice with mismatch between the nuclear and the mitochondrial genome.
  16. (2007). Deletion-mutant mtDNA increases in somatic tissues but decreases in female germ cells with age.
  17. (2007). Depletion of mitochondrial DNA in leukocytes harboring the 3243A-.G mtDNA mutation.
  18. (2008). Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis.
  19. (2006). Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants.
  20. (1995). Different cellular backgrounds confer a marked advantage to either mutant or wild-type mitochondrial genomes.
  21. (1996). Do sequence variants in the major non-coding region of the mitochondrial genome influence mitochondrial mutations associated with disease.
  22. (2007). Effects of granulosa cell mitochondria transfer on the early development of bovine embryos in vitro.
  23. (1996). Elaboration of the messenger transport organizer pathway for localization of RNA to the vegetal cortex of Xenopus oocytes.
  24. (2010). Embryo mitochondrial DNA depletion is reversed during early embryogenesis in cattle.
  25. (1998). Evidence from human oocytes for a genetic bottleneck in an mtDNA disease.
  26. (2000). Expression of Rattus norvegicus mtDNA in Mus musculus cells results in multiple respiratory chain defects.
  27. (2008). Fission and selective fusion govern mitochondrial segregation and elimination by autophagy.
  28. (2000). Functional constraints of nuclearmitochondrial DNA interactions in xenomitochondrial rodent cell lines.
  29. (2005). Gene therapy for progeny of mito-mice carrying pathogenic mtDNA by nuclear transplantation.
  30. (2000). Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes.
  31. (2004). Genetic and epigenetic modifications associated with human ooplasm donation and mitochondrial heteroplasmy - considerations for interpreting studies of heritability and reproductive outcome.
  32. (2009). Healthy baby girl born following pre-implantation Genetic diagnosis for mitochondrial DNA m.8993t.g Mutation.
  33. (1995). Homology between mitochondriogenesis in the avian and amphibian oocyte.
  34. (1997). Homopolymeric tract heteroplasmy in mtDNA from tissues and single oocytes: support for a genetic bottleneck.
  35. (1991). Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies.
  36. (2010). Information for genetic management of mtDNA disease: Sampling pathogenic mtDNA mutants in the human germline and in placenta.
  37. (1995). Inhibitors of oxidative stress mimic the ability of follicle-stimulating hormone to suppress apoptosis in cultured rat ovarian follicles.
  38. (1991). Introduction of disease related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction.
  39. (1999). Introduction of heteroplasmic mitochondrial DNA (mtDNA) from a patient with NARP into two human rho degrees cell lines is associated either with selection and maintenance of NARP mutant mtDNA or failure to maintain mtDNA.
  40. (1998). Is the bottleneck cracked?
  41. (2010). Is the mitochondrial cloud the selection machinery for preferentially transmitting wild-type mtDNA between generations? Rewinding Muller’s ratchet efficiently.
  42. (1996). Leber’s hereditary optic neuropathy: heteroplasmy is likely to be significant in the expression of LHON in families with the 3460 ND1 mutation.
  43. (1992). Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy.
  44. (2006). Mitochondria directly influence fertilisation outcome in the pig.
  45. (1997). Mitochondria transfer into mouse ova by microinjection.
  46. (2008). Mitochondrial behavior during oogenesis in zebrafish: a confocal microscopy analysis.
  47. (2003). Mitochondrial DNA modifies cognition in interaction with the nuclear genome and age in mice.
  48. (1988). Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy.
  49. (1999). Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue- or agerelated variation.
  50. (2004). Mitochondrial DNA turnover occurs during preimplantation development and can be modulated by environmental factors.
  51. (1994). Mitochondrial DNA: does more lead to less?
  52. (2009). Mitochondrial dynamics—fusion, fission, movement, and mitophagy—in neurodegenerative diseases.
  53. (2009). Mitochondrial gene replacement in primate offspring and embryonic stem cells.
  54. (1998). Mitochondrial genotype segregation during preimplantation development in mouse heteroplasmic embryos.
  55. (2005). Molecular control of mitochondrial function in preimplantation mouse embryos.
  56. (2006). Moscaicism for mitochondrial DNA polymorphic variants in placenta has implications for the feasibility of prenatal diagnosis in mtDNA diseases.
  57. (2007). Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body.
  58. (1992). Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness.
  59. (2009). New evidence confirms that the mitochondrial bottleneck is generated without reduction of mitochondrial DNA content in early primordial germ cells of mice.
  60. (2003). Nuclear genetic control of mitochondrial DNA segregation.
  61. (2007). Nuclear transfer: preservation of a nuclear genome at the expense of its associated mtDNA genome(s). In:
  62. (1983). Nucleotide sequence evidence for rapid genotypic shifts in the bovine mitochondrial DNA D-loop.
  63. (2009). Preimplantation genetic diagnosis for mitochondrial DNA disorders: ethical guidance for clinical practice.
  64. (2006). Prenatal diagnosis of MELAS syndrome: contribution to understanding mitochondrial DNA segregation during human embryo fetal development.
  65. (2010). Previous Estimates of Mitochondrial DNA Mutation Level Variance Did Not Account for Sampling Error: Comparing the mtDNA Genetic Bottleneck in Mice and Humans.
  66. (1990). Progressive increase of the mutated mitochondrial DNA fraction in KearnsSayre syndrome.
  67. (2010). Pronounced segregation of donor mitochondria introduced by bovine ooplasmic transfer to the female germ-line.
  68. (2010). Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease.
  69. (2003). Prospect of preimplantation genetic diagnosis for heritable mitochondrial DNA diseases.
  70. (1997). Prospects for DNA-based Prenatal Diagnosis of Mitochondrial Disorders.
  71. (2008). Purifying selection of mtDNA and its implications for understanding evolution and mitochondrial disease.
  72. (2001). Random genetic drift determines the level of mutant mtDNA in human primary oocytes.
  73. (1996). Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA.
  74. (1989). Rapid sequestration of heteroplasmic bovine mitochondria.
  75. (2010). Reassessing evidence for a postnatal mitochondrial genetic bottleneck.
  76. (1999). Relaxed replication of mtDNA: A model with implications for the expression of disease.
  77. (2004). Risk of developing a mitochondrial DNA deletion disorder.
  78. (2004). Role of the mitochondrial genome in assisted reproductive technologies and embryonic stem cell-based therapeutic cloning.
  79. (2008). Selection against Pathogenic mtDNA Mutations in a Stem Cell Population Leads to the Loss of the 3243A.G Mutation in Blood.
  80. (2001). Selection of a mtDNA sequence variant in hepatocytes of heteroplasmic mice is not due to differences in respiratory chain function or efficiency of replication.
  81. (1996). Sheep cloned by nuclear transfer from a cultured cell line.
  82. (1997). Skewed segregation of the mtDNA nt 8993 (T-.G) mutation in human ocytes.
  83. Spradling AC (2006) Milton controls the early acquisition of mitochondria by Drosophila oocytes.
  84. (2008). Strong purifying selection in transmission of mammalian mitochondrial DNA.
  85. (2001). Suomalainen A
  86. (2001). Synthesis of mitochondrial DNA in permeabilised human cultured cells.
  87. (2004). The Balbiani body and germ cell determinants: 150 years later.
  88. (2008). The distribution of mitochondrial DNA heteroplasmy due to random genetic drift.
  89. (2004). The functional organization of mitochondrial genomes in human cells.
  90. (2000). The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both?
  91. (2007). The mitochondrial bottleneck occurs without reduction of mtDNA content in female mouse germ cells.
  92. (2008). The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes.
  93. (2007). The mitochondrial transcription termination factor mTERF modulates replication pausing in human mitochondrial DNA.
  94. (1997). Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice.
  95. (1995). Transmission of mtDNA: Cracks in the bottleneck.
  96. (2003). Transmission, genetic counselling and prenatal diagnosis of mitochondrial DNA disease. In:
  97. (1995). Two distinct pathways for the localization of RNAs at the vegetal cortex in Xenopus oocytes.
  98. (1988). Unequal partitioning of bovine mitochondrial genotypes among siblings.
  99. (2008). Variations in mouse mitochondrial DNA copy number from fertilization to birth are associated with oxidative stress.